Company page

Codexis, Inc.

Codexis, Inc. is a public company traded under the ticker CDXS in the American market. With a market capitalization of approximately $233.6 million, Codexis focuses on developing innovative enzyme-based solutions for various industries. The company is committed to advancing biotechnology and improving product efficiency through its proprietary technology.